Dextroamphetamine is the dextrorotatory enantiomer of amphetamine[A2505]. Dextroamphetamine was approved by the FDA in 2001 for the treatment of attention deficit hyperactivity disorder[L6010,Label].
Synonyms
Dextroamphetamine saccharate
Dextroamphetamine
Dexamphetamine
(αS)-α-methylbenzeneethanamine
(S)-1-phenyl-2-aminopropane
Dexanfetamina
(S)-amphetamine
(+)-α-methylphenethylamine
(S)-(+)-amphetamine
Dextroamphetamine sulfate
(S)-α-methylbenzeneethanamine
(+)-(S)-amphetamine
(S)-1-phenyl-2-propylamine
Desamfetamina
Dexamfetamine
(+)-amphetamine
(S)-(+)-β-phenylisopropylamine
(+)-α-methylphenylethylamine
Dexamfetaminum
d-amphetamine
Dextroamphetamine adipate
Dexamfetamina
Brand Names
Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate ER
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
